logo-loader
TSX:NVCN NASDAQ:NVCN

Neovasc

Receive alerts
Market:
TSX
Market Cap:
$39.97 m
Price
3.59 CAD
Change
-1.64%
52 weeks high
11.40
52 weeks low
3.13

In brief

Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Reducer, for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada and Europe.